Population-based retrospective nested case-control study evaluating effectiveness of GARDASIL™ /GARDASIL™9 against adult-onset recurrent respiratory papillomatosis (AoRRP) in Sweden, Denmark, and Norway (V503-088)

First published 05/10/2022

Last updated 21/05/2025

EU PAS number:

EUPAS48452

Study

Ongoing

Documents

Study protocol

Initial protocol

V503-088-00-v2.1-Protocol_final redaction

English (513.37 KB - PDF)View document

Updated protocol

V503-088-01-v1-final-redaction.pdf

First published: 11/09/2024

English (722.91 KB - PDF)View document

Study results

Study report

Other information

Secondary tabs